Multiple Myelomas
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Predictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose Therapy (NCT01085058) | WiSP Wissenschaftlicher Service Pharma GmbH | 2003-05-01 |
Track Multiple Myelomas automatically
Every clearance here is in the API, with alerts when new ones post.